Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants.
Open Access
- 15 July 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 145 (2) , 561-568
- https://doi.org/10.4049/jimmunol.145.2.561
Abstract
To study the active site(s) of IL-6 we combined mutagenesis of IL-6 with epitope mapping of IL-6 specific mAb. In addition to amino-terminal deletion mutants we described previously, carboxyl-terminal deletion mutants were prepared. Functional analysis showed that deletion of only five carboxyl-terminal amino acids already reduced the bioactivity 1000-fold. A panel of mAb to IL-6 was subsequently analyzed by antibody competition experiments and binding to the amino- and carboxyl-terminal deletion mutants. On the basis of the competition experiments the six neutralizing mAb were divided in two groups (I and II). The binding pattern with the deletion mutants suggested that the region recognized by the four mAb in group I is composed of residues of amino- and carboxyl-terminus: binding of two mAb was abolished after deletion of amino acid Ala I-Ile26, of the third mAb after deletion of the four carboxyl-terminal amino acids whereas the fourth mAb did not bind to either mutant. Group II mAb retained binding to these mutants. Taken together these data suggest that in the native IL-6 molecule amino acid residues of amino and carboxyl terminus are in close proximity and that together they constitute an active site. Furthermore our data suggest that the part of the molecule recognized by group II antibodies is a second site involved in biologic activity.This publication has 27 references indexed in Scilit:
- ELEVATED LEVELS OF THE 26K HUMAN HYBRIDOMA GROWTH-FACTOR (INTERLEUKIN-6) IN CEREBROSPINAL-FLUID OF PATIENTS WITH ACUTE INFECTION OF THE CENTRAL NERVOUS-SYSTEM1988
- Murine monoclonal isotype switch variants detection with rat monoclonal antibodies in ELISA and isolation by sequential subliningJournal of Immunological Methods, 1988
- Molecular cloning and expression of hybridoma growth factor in Escherichia coli.The Journal of Immunology, 1987
- Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression.The Journal of Experimental Medicine, 1987
- Monoclonal anti-peroxidase isotype switch variantsJournal of Immunological Methods, 1987
- Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1.The Journal of Immunology, 1987
- High‐affinity binding sites for human 26‐kDa protein (interleukin 6, B cell stimulatory factor‐2, human hybridoma plasmacytoma growth factor, interferon‐β2), different from those of type I interferon (α,β), on lymphoblastoid cellsEuropean Journal of Immunology, 1987
- Production of hybridoma growth factor by human monocytesEuropean Journal of Immunology, 1987
- A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo.The Journal of Immunology, 1981
- Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteinsJournal of Molecular Biology, 1978